Genetic Technologies
GENE
#10486
Rank
โ‚ฌ3.18 M
Marketcap
0,66ย โ‚ฌ
Share price
0.00%
Change (1 day)
-71.50%
Change (1 year)

Genetic Technologies (GENE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ2.5 Million

According to Genetic Technologies's latest financial reports the company's total liabilities are โ‚ฌ2.5 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Genetic Technologies - Total liabilities on balance sheet (from 2004 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚ฌ2.71 M21.24%
2023-06-30โ‚ฌ2.24 M-21.95%
2022-06-30โ‚ฌ2.87 M214.82%
2021-06-30โ‚ฌ0.91 M-9.13%
2020-06-30โ‚ฌ1 M8.7%
2019-06-30โ‚ฌ0.92 M0.35%
2018-06-30โ‚ฌ0.91 M-10.7%
2017-06-30โ‚ฌ1.02 M8.87%
2016-06-30โ‚ฌ0.94 M-22.02%
2015-06-30โ‚ฌ1.21 M-64.01%
2014-06-30โ‚ฌ3.37 M87.4%
2013-06-30โ‚ฌ1.79 M9.02%
2012-06-30โ‚ฌ1.64 M6.1%
2011-06-30โ‚ฌ1.55 M-9.76%
2010-06-30โ‚ฌ1.72 M-21.81%
2009-06-30โ‚ฌ2.2 M9.46%
2008-06-30โ‚ฌ2.01 M-4.47%
2007-06-30โ‚ฌ2.1 M-13.94%
2006-06-30โ‚ฌ2.44 M-41.15%
2005-06-30โ‚ฌ4.16 M37.74%
2004-06-30โ‚ฌ3.02 M91.7%
2003-06-30โ‚ฌ1.57 M33.97%
2002-06-30โ‚ฌ1.17 M29.65%
2001-06-30โ‚ฌ0.9 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ2.23 M-10.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚ฌ0.30 B 12,086.42%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ8.19 B 327,407.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ7.57 B 302,451.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ46.38 M 1,752.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚ฌ24.74 B 988,293.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ44.53 B 1,778,850.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ1.08 B 43,099.89%๐Ÿ‡บ๐Ÿ‡ธ USA